ADMA Biologics Inc - Common Stock (NQ:ADMA)

9.720 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

ADMA Biologics Inc (ADMA) Q1 2021 Earnings Call Transcript ↗

May 12, 2021

ADMA earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: ADMA Biologics Q1 Earnings ↗

May 12, 2021

Shares of ADMA Biologics (NASDAQ:ADMA) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 38.46% over the...

Via Benzinga

ADMA Biologics Earnings Preview ↗

May 11, 2021

On Wednesday, May 12, ADMA Biologics (NASDAQ:ADMA) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release....

Via Benzinga

ADMA Stock: The Big FDA News Boosting ADMA Biologics Today ↗

April 28, 2021

Today, ADMA stock is a big mover as the company announced a very bullish FDA approval allowing the company to scale its core product.

Via InvestorPlace

Why Is It Moving? Looking At ADMA Biologics's Price Action Today ↗

April 28, 2021

ADMA Biologics's Stock Price And Volume Action ADMA Biologics's (NASDAQ:

Via Benzinga

ADMA Biologics Shares Jump On Increased Manufacturing Capacity For Intravenous Immune Globulin ↗

April 28, 2021

The FDA has approved ADMA Biologics Inc's (NASDAQ: ADMA) expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma...

Via Benzinga

ADMA Biologics Breaks Downtrend And May Rally ↗

April 22, 2021

After a painful two months, shareholders of ADMA Biologics (NASDAQ:ADMA) may final...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

Earnings Scheduled For May 12, 2021 ↗

May 12, 2021

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex ↗

April 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.